Release Date: 29/07/20 09:27 Summary: Positive cashflow and continued ARR growth in Q4 Price Sensitive: Yes Download Document 485.33KB Download
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution